GSK, McEnroe urge over-40 men to get tested for prostate cancer

Share this article:
GSK, McEnroe urge over-40 men to get tested for prostate cancer
GSK, McEnroe urge over-40 men to get tested for prostate cancer
GlaxoSmithKline recruited tennis great John McEnroe for an awareness campaign about prostate cancer.

The print PSA campaign, by the Entertainment Industry Foundation's Stand Up To Cancer initiative, features an image of McEnroe having just had blood drawn and the tagline “Get serious,” urging men over 40 to get tested for the disease. The copy relates McEnroe's surprise upon learning, following his father's diagnosis with prostate cancer, that one in six men in the US gets the disease.

In addition to the print PSA, McEnroe put in appearances on CNN's Larry King, CBS's Early Show and Fox's Hannity to urge men over 40 to get tested. Ads will run in magazines like Fortune, People and Sports Illustrated.

Robert Perry, senior director, US product communications at GSK, said McEnroe gets the attention of men in the target age cohort. “They've shared their adult years with him and seen him go from rebel to statesman,” said Perry.  
Creative was handled by McCann HumanCare, while GSK's men's health agency, Taylor PR, handled communications.

GSK helped develop the campaign and funded it, including compensating McEnroe, whom the company had been in talks with before it joined Stand Up To Cancer. McEnroe is 50 – the age at which men were, until recently, urged to get tested for prostate cancer. In April, the American Urological Association, a partner in the campaign, revised its recommendations to advise men 40 and up get a Prostate-Specific Antigen, or PSA, test.

In addition to GSK, the Electronic Industry Foundation and the AUA, partners in the campaign included Men's Health Network, Prostate Cancer Foundation and the Prostate Conditions Education Council.

Stand Up To Cancer partnered with Amgen on another recent celeb-driven educational campaign, this one featuring Edie Falco and Cynthia Nixon, advising patients on the risk of infection during treatment in 30- and 60-second broadcast spots as well as print ads and a website, www.manageyourtreatment.com.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...